ADNEXUS



Trademark Coverage

No Class Specified

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Timeline
  • Aug 05
    2013
    Abandonment Notice Mailed No Use Statement Filed
  • Aug 05
    2013
    Abandonment No Use Statement Filed
  • Mar 12
    2013
    TEAS Change Of Correspondence Received
  • Dec 29
    2012
    Notice Of Approval Of Extension Request E Mailed
  • Dec 27
    2012
    Extension 1 Granted
  • Dec 27
    2012
    Extension 1 Filed
  • Dec 27
    2012
    TEAS Extension Received
  • Jul 03
    2012
    NOA E Mailed SOU Required From Applicant
  • May 08
    2012
    Official Gazette Publication Confirmation E Mailed
  • May 08
    2012
    Published For Opposition
  • Apr 18
    2012
    Notification Of Notice Of Publication E Mailed
  • Mar 31
    2012
    Law Office Publication Review Completed
  • Mar 31
    2012
    Assigned To LIE
  • Mar 13
    2012
    Approved For PUB Principal Register
  • Mar 09
    2012
    Assigned To Examiner
  • Feb 21
    2012
    New Application Office Supplied Data Entered In TRAM
  • Feb 16
    2012
    New Application Entered In TRAM